Search results for

The effects of the war in Iran are far-reaching, extending to drivers for DoorDash and Uber Eats. They're paying more for gas — and being squeezed by competition. DoorDash is rolling out some relief.

In addition to his kung fu and action films, Norris, who died March 19, starred in the TV show Walker, Texas Ranger. He spoke with Terry Gross in 1988 about learning karate while stationed in Korea.

Minutes before President Trump delayed plans to attack Iran's energy infrastructure, big trades were made, raising insider trading concerns. NPR's A Martinez asks economist Paul Krugman.

NPR's Steve Inskeep asks retired Lt. Gen. Sean MacFarland about the rapid deployment capabilities of the 82nd Airborne and the strategic advantages those troops provide.

President Trump said he'll hold off on striking Iran's power plants until April 6, postponing a deadline for Iran to let ships transit safely through the Strait of Hormuz.

The Supreme Court is considering whether to limit when mail-in ballots can be counted in states across the U.S. NPR's Michel Martin discusses with Amy Howe of SCOTUSblog.

The roots music maverick did something rare in the streaming era: landed an album that's only available on CD, cassette and LP — without his name on the sleeve — in the top five of the albums chart.

Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." Nutritionists help us decode that message.

Data brokers buy up huge amounts of information from cell phones and browsers to sell for targeted advertising. But the government, including ICE, also buys the data.

How has Iran's negotiating position changed after weeks of war? NPR's A Martinez talks to Mohammad Ali Shabani, editor of the London-based news site Amwaj.media.

The Arab countries of the Gulf opposed the U.S. war in Iran. Yet they face some of the heaviest attacks from Iran and feel the war could leave them less secure than when the fighting began.

The antibody shots are about 80% effective at preventing babies from ending up in intensive care because of RSV. The drugmakers behind them maintain they're safe.